Apyx Medical
10
0
0
10
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 10 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
100%
10 of 10 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
Histological Evaluation of Human Skin Bx to Assess the Effects of APR Tx as an Adjunct Procedure in Facelift Surgery
Role: lead
Evaluation of the Use of the Renuvion APR System in the Labia
Role: lead
A Post-Market Study in Greece of a Minimally Invasive Breast Lift Procedure Utilizing the Renuvion APR System
Role: lead
Post-Market Lower Eyelid Treatment With Renuvion in Greece
Role: lead
Measuring Renuvion Soft Tissue Contraction Using Ultrasound
Role: lead
Renuvion APR System When Used as an Adjunct Procedure In Gynecomastia Surgery
Role: lead
The Use of J-Plasma® for Dermal Resurfacing
Role: lead
Renuvion APR Device to Improve the Appearance of Lax Tissue in the Neck and Submental Region
Role: lead
Renuvion Dermal System for Dermal Resurfacing
Role: lead
Cold Plasma for the Reduction of Lymphoceles Following PLND
Role: lead
All 10 trials loaded